This ticker has not been starred yet REVB Revelation Biosciences, Inc.
Pharmaceutical Preparations
Book value per $ invested $ 0.49
Leverage 29.09%
Market Cap $ 7.9m
PE 0.00
Dividend Yield 0.00%
Profit $ -8.4m
Margin 134.92%

Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of immunological diagnostics and therapeutics for the prevention and treatment of disease. The company is headquartered in New York, New York.

Subscribe Now For Access - Only $1.99 Per Month